{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:55:22Z","timestamp":1788965722223,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A2096"],"award-info":[{"award-number":["U23A2096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52173125"],"award-info":[{"award-number":["52173125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jcis.2024.09.016","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T12:52:01Z","timestamp":1725454321000},"page":"750-762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"PB","title":["A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy"],"prefix":"10.1016","volume":"678","author":[{"given":"Keze","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8349-7555","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcis.2024.09.016_b0005","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.359.6382.1344","article-title":"The cancer immunotherapy revolution","volume":"359","author":"Kelly","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jcis.2024.09.016_b0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.immuni.2019.12.010","article-title":"Human anti-tumor immunity: insights from immunotherapy clinical trials","volume":"52","author":"Egen","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jcis.2024.09.016_b0015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(20)32598-8","article-title":"Enhancing anti-tumour effi cacy with immunotherapy combinations","volume":"397","author":"Meric-Bernstam","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcis.2024.09.016_b0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-line immunotherapy for non-small-cell lung cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcis.2024.09.016_b0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jamaoncol.2017.3462","article-title":"Association of first-in-class immune checkpoint in hibition and targeted therapy with survival in patients with stage IV melanoma","volume":"4","author":"Sinnamon","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jcis.2024.09.016_b0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41571-023-00763-0","article-title":"Adding immune-checkpoint inhibitors to chemotherapy extends sur vival in endometrial cancer","volume":"20","author":"Romero","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jcis.2024.09.016_b0035","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-Catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jcis.2024.09.016_b0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40779-023-00455-x","article-title":"Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy","volume":"10","author":"Ma","year":"2023","journal-title":"Military Med. Res."},{"key":"10.1016\/j.jcis.2024.09.016_b0045","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1158\/0008-5472.CAN-06-3304","article-title":"Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer","volume":"67","author":"Hinz","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jcis.2024.09.016_b0050","doi-asserted-by":"crossref","first-page":"20180214","DOI":"10.1098\/rstb.2018.0214","article-title":"Immunotherapy: breaching the barriers for cancer treatment","volume":"374","author":"Martinez","year":"2019","journal-title":"Phil. Trans. r. Soc. b."},{"key":"10.1016\/j.jcis.2024.09.016_b0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4049\/jimmunol.1701269","article-title":"Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity","volume":"200","author":"Engelhard","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.jcis.2024.09.016_b0060","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jcis.2024.09.016_b0065","doi-asserted-by":"crossref","unstructured":"M.M. Melssen, N.D. Sheybani, K.M. Leick, C.L. Slingluff Jr., Barriers to immune cell infiltration in tumors, J. Immunother. Cancer 11 (2023) e006401, https:\/\/doi.org\/10.1136\/jitc-2022-006401.","DOI":"10.1136\/jitc-2022-006401"},{"key":"10.1016\/j.jcis.2024.09.016_b0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","article-title":"Deciphering and reversing tumor immune suppression","volume":"39","author":"Motz","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jcis.2024.09.016_b0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.30593","article-title":"Blocking triggering receptor expressed on myeloid cells-1-positive tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-programmed cell death ligand 1 resistance in liver cancer","volume":"70","author":"Wu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcis.2024.09.016_b0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mattod.2023.07.003","article-title":"Biomimetic multifunctional nanodrugs enable regulating abnormal tumor metabolism and amplifying PDT-induced immunotherapy for synergistically enhanced tumor ablation","volume":"68","author":"Liu","year":"2023","journal-title":"Mater. Today"},{"key":"10.1016\/j.jcis.2024.09.016_b0085","doi-asserted-by":"crossref","first-page":"2100595","DOI":"10.1002\/adma.202100595","article-title":"Supramolecular nanofibrils formed by coassembly of clinically approved drugs for tumor photothermal immunotherapy","volume":"33","author":"Li","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jcis.2024.09.016_b0090","doi-asserted-by":"crossref","unstructured":"J. Watt, H.M. Kocher, The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration, Oncoimmunology 2 (2013) e26788, https:\/\/doi.org\/10.4161\/onci.26788.","DOI":"10.4161\/onci.26788"},{"key":"10.1016\/j.jcis.2024.09.016_b0095","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2024.01.050","article-title":"Anti-stromal nanotherapeutics for hepatocellular carcinoma","volume":"367","author":"Yu","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jcis.2024.09.016_b0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.actbio.2023.08.007","article-title":"A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer","volume":"169","author":"Wang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jcis.2024.09.016_b0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jconrel.2023.02.029","article-title":"Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy","volume":"356","author":"Xiao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jcis.2024.09.016_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101490","article-title":"Nanodrug simultaneously regulates stromal extracellular matrix and glucose metabolism for effective immunotherapy against orthotopic pancreatic cancer","volume":"44","author":"Xiao","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jcis.2024.09.016_b0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41565-022-01122-3","article-title":"Enhancing CRISPR\/Cas gene editing through modulating cellular mechanical properties for cancer therapy","volume":"17","author":"Zhang","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jcis.2024.09.016_b0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.actbio.2022.10.008","article-title":"Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment","volume":"154","author":"Li","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jcis.2024.09.016_b0125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jcis.2024.09.016_b0130","first-page":"57","article-title":"Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation","volume":"21","author":"Xiao","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jcis.2024.09.016_b0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jcis.2024.09.016_b0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jcis.2024.09.016_b0145","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41563-018-0093-6","article-title":"Dendritic cells in cancer immunotherapy","volume":"17","author":"Le Gall","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jcis.2024.09.016_b0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12885-019-5670-9","article-title":"Induction of tolerogenic dendritic cells by activated TGF-\/Akt\/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells","volume":"19","author":"Zhong","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcis.2024.09.016_b0155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.adg1955","article-title":"Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape","volume":"383","author":"Sharma","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jcis.2024.09.016_b0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2020.12.023","article-title":"Stanni ocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance","volume":"39","author":"Lin","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcis.2024.09.016_b0165","doi-asserted-by":"crossref","unstructured":"Y.J. Cai, G.J. Chen, M.Z. Lin, B. Li, H.H. Zhong, T. Li, Z.C. Xiao, Y. Wang, X.T. Shuai, Twins like nanodrugs synchronously transport in blood and coalesce inside tumors for sensitive ultrasound imaging and triggerable penetrative drug delivery, Aggregate 5 (2024) e476, https:\/\/doi.org\/10.1002\/agt2.476.","DOI":"10.1002\/agt2.476"},{"key":"10.1016\/j.jcis.2024.09.016_b0170","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s11426-019-9699-3","article-title":"Responsive boron biomaterials and their biomedical applications","volume":"63","author":"Chen","year":"2020","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.jcis.2024.09.016_b0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tifs.2016.07.004","article-title":"The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review","volume":"56","author":"Wang","year":"2016","journal-title":"Trends Food Sci. Tech."},{"key":"10.1016\/j.jcis.2024.09.016_b0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41578-020-00233-4","article-title":"Functional nanoparticles through \u03c0-conjugated polymer self-assembly","volume":"6","author":"MacFarlane","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jcis.2024.09.016_b0185","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/acs.biomac.2c00482","article-title":"Phenylboronic acid-functionalized copolypeptides: facile synthesis and responsive dual anticancer drug re lease","volume":"23","author":"Zhang","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jcis.2024.09.016_b0190","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1021\/nn3059295","article-title":"Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge","volume":"7","author":"Huehn","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jcis.2024.09.016_b0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell sub populations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jcis.2024.09.016_b0200","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jconrel.2022.11.011","article-title":"Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress","volume":"352","author":"Zhao","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jcis.2024.09.016_b0205","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/1078-0432.CCR-20-2564","article-title":"Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity","volume":"27","author":"Liang","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcis.2024.09.016_b0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jconrel.2022.09.009","article-title":"Tumor immunotherapy boosted by R837 nanocrystals through combining chemotherapy and mild hyperthermia","volume":"350","author":"Meng","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jcis.2024.09.016_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120636","article-title":"Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy","volume":"269","author":"Huang","year":"2021","journal-title":"Biomaterials"}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979724020745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979724020745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:52:24Z","timestamp":1778637144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979724020745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":43,"alternative-id":["S0021979724020745"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2024.09.016","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2024.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}